Skip to main content
Premium Trial:

Request an Annual Quote

The Data is Already Out There

The Business Bytes Genes Molecules blog's Deepak Singh says it may be time to put away the microarray gene expression experiments and pay attention to the data that's already been gathered by other researchers to get more focused on "useful science." Singh, who references Atul Butte's talk at the Sage Congress on publicly available data, says there will soon be sufficient public data available for "smart people ... to do a lot of interesting things, such as identifying data-driven candidate genes." The key lessons Butte presented, Singh says, are: sufficient data already exists to impact medicine, public molecular data is of high quality, imperfect annotations are still very useful, researchers should focus on using the tools they really need, and that students need to be trained to use data to "initiate science."

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.